Blue Bell Private Wealth Management LLC Acquires 44,866 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Blue Bell Private Wealth Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 37.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 164,064 shares of the company’s stock after purchasing an additional 44,866 shares during the quarter. Blue Bell Private Wealth Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $2,520,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Karpus Management Inc. grew its position in BlackRock Health Sciences Term Trust by 27.1% in the 4th quarter. Karpus Management Inc. now owns 1,217,589 shares of the company’s stock worth $17,838,000 after purchasing an additional 259,464 shares during the period. Weiss Asset Management LP bought a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth $2,669,000. Wolverine Asset Management LLC increased its position in BlackRock Health Sciences Term Trust by 1,569.0% during the second quarter. Wolverine Asset Management LLC now owns 190,839 shares of the company’s stock valued at $2,931,000 after acquiring an additional 179,405 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in BlackRock Health Sciences Term Trust by 66.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 399,964 shares of the company’s stock valued at $6,143,000 after acquiring an additional 159,401 shares during the last quarter. Finally, Lazard Asset Management LLC lifted its holdings in BlackRock Health Sciences Term Trust by 24.3% in the first quarter. Lazard Asset Management LLC now owns 798,962 shares of the company’s stock valued at $13,094,000 after acquiring an additional 156,417 shares during the period.

BlackRock Health Sciences Term Trust Stock Performance

BlackRock Health Sciences Term Trust stock opened at 15.86 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of 12.93 and a 52-week high of 16.59. The business has a 50-day simple moving average of 15.71 and a two-hundred day simple moving average of 15.58.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.176 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.11 annualized dividend and a yield of 13.32%.

BlackRock Health Sciences Term Trust Profile

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Articles

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.